Cadent Therapeutics to Be Acquired by Novartis for $210 Million Upfront and up to $560 Million in Milestones – CBI
Homepage /  Press Release /  Cadent Therapeutics to Be Acquired by Novartis for $210 Million Upfront and up to $560 Million in Milestones

Press Release

Cadent Therapeutics to Be Acquired by Novartis for $210 Million Upfront and up to $560 Million in Milestones